Bellinger Melissa A, Bean James S, Rader Melissa A, Heinz-Taheny Kathleen M, Nunes Jairo S, Haas Joseph V, Michael Laura F, Rekhter Mark D
Cardiometabolic Diseases and Diabetic Complications, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
Investigational Pathology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
PLoS One. 2014 Apr 2;9(4):e93297. doi: 10.1371/journal.pone.0093297. eCollection 2014.
Acute kidney injury (AKI) is a syndrome characterized by the rapid loss of the kidney excretory function and is strongly associated with increased early and long-term patient morbidity and mortality. Early diagnosis of AKI is challenging; therefore we profiled plasma microRNA in an effort to identify potential diagnostic circulating markers of renal failure. The goal of the present study was to investigate the dynamic relationship of circulating and renal microRNA profiles within the first 24 hours after bilateral ischemia-reperfusion kidney injury in mice.
METHODOLOGY/PRINCIPAL FINDINGS: Bilateral renal ischemia was induced in C57Bl/6 mice (n = 10 per group) by clamping the renal pedicle for 27 min. Ischemia-reperfusion caused highly reproducible, progressive, concordant elevation of miR-714, miR-1188, miR-1897-3p, miR-877*, and miR-1224 in plasma and kidneys at 3, 6 and 24 hours after acute kidney injury compared to the sham-operated mice (n = 5). These dynamics correlated with histologic findings of kidney injury and with a conventional plasma marker of renal dysfunction (creatinine). Pathway analysis revealed close association between miR-1897-3p and Nucks1 gene expression, which putative downstream targets include genes linked to renal injury, inflammation and apoptosis.
CONCLUSIONS/SIGNIFICANCE: Systematic profiling of renal and plasma microRNAs in the early stages of experimental AKI provides the first step in advancing circulating microRNAs to the level of promising novel biomarkers.
急性肾损伤(AKI)是一种以肾脏排泄功能迅速丧失为特征的综合征,与患者早期和长期发病率及死亡率增加密切相关。AKI的早期诊断具有挑战性;因此,我们对血浆微小RNA进行了分析,以确定肾衰竭潜在的循环诊断标志物。本研究的目的是探讨小鼠双侧缺血再灌注肾损伤后24小时内循环和肾脏微小RNA谱的动态关系。
方法/主要发现:通过夹闭肾蒂27分钟,在C57Bl/6小鼠(每组n = 10)中诱导双侧肾缺血。与假手术小鼠(n = 5)相比,急性肾损伤后3、6和24小时,缺血再灌注导致血浆和肾脏中miR-714、miR-1188、miR-1897-3p、miR-877*和miR-1224高度可重复、渐进且一致地升高。这些动态变化与肾损伤的组织学结果以及肾功能障碍的传统血浆标志物(肌酐)相关。通路分析显示miR-1897-3p与Nucks1基因表达密切相关,其推测的下游靶点包括与肾损伤、炎症和凋亡相关的基因。
结论/意义:对实验性AKI早期阶段的肾脏和血浆微小RNA进行系统分析,是将循环微小RNA提升至有前景的新型生物标志物水平的第一步。